Kwick Forensic Solutions Limited
Sector: Forensic Science & Law-Enforcement Technology Solutions (India)
1. Overview
Kwick Forensic Solutions Limited ("Kwick Forensic" / "the Company") is an Indian provider of end-to-end forensic science, crime-scene investigation and law-enforcement solutions, incorporated in 2005 and headquartered in Chennai, Tamil Nadu. The Company was originally established as a software developer focused on 3D rendering, animation and simulation for the construction sector, before pivoting into the forensic vertical from 2008 — an inflection point marked by its development of an Interactive Virtual Reality Crime Scene Simulator, built with funding support from the Ministry of Science & Technology, the Directorate of Forensic Science, and TIFAC.
From FY2015 onwards, the Company scaled into a full-spectrum forensic solutions provider, spanning fingerprint science, cyber/digital forensics, DNA forensics, social-media and big-data analytics, with a strategic emphasis on Total Evidence Management for India's police and forensic ecosystem. It supplies forensic tools and scientific kits, Mobile CSI Vehicles (MCSIV), handheld field devices and DNA databasing platforms, and additionally rents forensic equipment such as handheld liquor-detection scanners.
The Company's scale has expanded rapidly. Revenue from Operations grew from ₹30.18 Cr in FY2024 to ₹65.03 Cr in FY2025 and further to ₹105.71 Cr in FY2026, while Profit After Tax rose from ₹2.83 Cr to ₹8.56 Cr to ₹13.51 Cr over the same period. The Company maintains a sales and marketing presence across major Indian states and serves a mix of government and private clients, positioning itself in a specialized niche with no listed comparable peer offering a similar end-to-end proposition.
Kwick Forensic is led by Founder & Managing Director Mr. Shammer Saralal Shah (40+ years of experience across electronics, forensics and IT),.
2. Business Model and Revenue Streams
Kwick Forensic's revenue is derived from two primary streams — Sales of Goods and Sales of Services. Within Sales of Goods, the Company operates across four forensic product segments; Sales of Services comprises rental of forensic equipment and AMC/other services.
Segment-Wise Revenue Breakup
| Segment | FY2026 | % | FY2025 | % | FY2024 | % |
|---|---|---|---|---|---|---|
| Forensic Science & Physical Evidence Solutions | 39.11 | 36.99% | 18.59 | 28.59% | 11.79 | 39.05% |
| Mobile CSI Vehicles (MCSIV) | 10.57 | 10.00% | 16.41 | 25.23% | 4.05 | 13.42% |
| Cyber & Digital Forensics | 35.23 | 33.32% | 15.07 | 23.18% | 6.42 | 21.28% |
| DNA Forensics | 11.38 | 10.76% | 6.16 | 9.47% | 0.43 | 1.41% |
| Sub-total — Sales of Goods | 96.28 | 91.08% | 56.23 | 86.47% | 22.69 | 75.17% |
| Renting of Forensic Equipment | 9.25 | 8.75% | 8.40 | 12.92% | 6.71 | 22.24% |
| AMC & Other Services | 0.18 | 0.17% | 0.40 | 0.61% | 0.78 | 2.59% |
| Sub-total — Sales of Services | 9.43 | 8.92% | 8.80 | 13.53% | 7.49 | 24.83% |
| TOTAL | 105.71 | 100.00% | 65.03 | 100.00% | 30.18 | 100.00% |
Pricing, Contracting & Client Model
- Contract model: The Company generally engages OEM suppliers on a deal-to-deal basis and via long-term non-exclusive distribution agreements or purchase orders — providing flexibility while preserving cost and supply-chain leverage.
- Client acquisition: Primarily through GeM (Government e-Marketplace) and other e-procurement portals, alongside direct quotations and referrals.
- Customer base: Police stations, central and state Forensic Science Laboratories (FSLs), central and state fingerprint bureaus, crime investigation departments (CIDs), police training academies, and universities offering forensic science courses.
Concentration & Dependency (Key Risk Flags)
- Government concentration: The Company derived 86.98%, 78.91% and 55.22% of revenue from transactions with government entities/agencies in FY2026, FY2025 and FY2024 respectively — a rising dependency on public-sector demand.
- Geographic concentration: Products and services are significantly concentrated in Bihar and Gujarat.
- Import dependency: Products are sourced from international markets including China, USA, Turkey, Japan and Italy, though the Company has steadily localized — domestic sourcing rose to 91.35% of raw-material requirements in FY2026 (from 65.42% in FY2024).
3. Products and Service Portfolio
Kwick Forensic's offerings span every stage of forensic investigation — Pre-Collection, Collection and Post-Collection — with a focus on evidence identification, collection and tamper-evident digitization for court admissibility.
A. Forensic Products and Vehicles (Sales of Goods) (₹ Cr)
| Sr No. | Product Segment | Description | FY2026 Revenue |
|---|---|---|---|
| 1 | Forensic Science & Physical Evidence Solutions | Forensic/scientific kits & consumables (14 standard kits), handheld forensic devices, controlled-environment chambers/cabinets | 39.11 |
| 2 | Mobile CSI Vehicles (MCSIV) | Fully-equipped Micro, Mini and Macro mobile crime-scene investigation vehicles supplied to districts and police stations | 10.57 |
| 3 | Cyber & Digital Forensics | Digital forensics tools, cyber investigation and evidence-analysis platforms | 35.23 |
| 4 | DNA Forensics | Sexual assault evidence kits, genetic analyzers, DNA database systems, Rapid DNA (Rapid HT) and SmallPond DNA databasing software (authorised non-exclusive reseller in India) | 11.38 |
B. Services
Rental / Sub-lease of Forensic Equipment — e.g., handheld scanners for liquor detection, and detection/scanning/X-ray imaging systems, bundled with manpower support where required (₹9.25 Cr in FY2026).
In-House / "Make in India" Developments
The R&D team has commercialized proprietary devices previously imported, including:
CSI Pro — Forensic Evidence Search and Capture Smart Device
Multispectral Tablet — handheld system with forensic light source to detect body fluids
Quality & Accreditation
The Company holds ISO 9001:2015, ISO 14001:2015, ISO/IEC 20000-1:2018 and ISO/IEC 27001:2022 certifications, and is registered with MSME, DSIR and NSIC.
4. Key Business Strengths
- Strategic OEM relationships with global leaders: Long-standing ties with Sirchie (USA), Thermo Fisher Scientific, Invitrogen, Rapiscan Systems, SmallPond and Seratec, securing quality equipment at scale and a reliable supply chain.
- Niche market positioning with high entry barriers: Operates in a specialized end-to-end forensic segment with no listed comparable competitor; a decade of trusted government relationships creates significant barriers to entry.
- Robust quality management & certifications: ISO-certified across quality, environmental, IT-service and information-security management systems, with documented SOPs and pre-dispatch checks.
- Diversified forensic portfolio: Balanced revenue across four product segments plus services, reducing single-product dependency.
- Progressive import substitution: Domestic sourcing scaled to 91.35% of raw materials in FY2026, improving gross margins and reducing forex exposure.
- Experienced, founder-led management: Led by a Managing Director with 40+ years of sector experience, supported by a specialized sales and R&D organization.
5. Future Growth Strategy
- Riding government forensic-modernization spending: The Government has approved ₹200 Cr (₹20,000 Lakh) for Modernization/Upgradation of Forensic Science Laboratories across 20 States, and ₹185.28 Cr for strengthening DNA and Cyber Forensic capacities in State FSLs — a direct tailwind for the Company's core segments.
- Capitalizing on the BNSS/BNS/BSA legal transformation: The new criminal laws (effective July 1, 2024) mandate tamper-proof digitization of search, seizure and evidence handling, expanding demand for digital forensics and secure evidence-management solutions.
- Asset-light MCSIV collaboration model: Shift toward supplying scientific/digital kits through local dealers and vehicle manufacturers (95 vehicles executed in FY2026 contributing ₹20.36 Cr), reducing working-capital intensity while sustaining project execution.
- Scaling DNA & Cyber forensics: DNA Forensics grew ~14.4x in FY2025 and ~1.85x in FY2026; Cyber & Digital Forensics grew ~2.35x and ~2.34x across the same years — the fastest-growing verticals.
- In-house product development under "Make in India": Continued localization of evidence-collection equipment for faster support and improved margins.
Delete Comment?
Are you sure you want to delete this comment? This action cannot be undone.
Discussion
Join the discussion!
Log In to CommentNo comments yet. Be the first to share your thoughts!